- Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
- Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
- Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
- Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
- Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
- Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
More ▼
Key statistics
As of last trade Arcturus Therapeutics Holdings Inc (ARCT:NMQ) traded at 31.04, -29.15% below its 52-week high of 43.81, set on Feb 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 32.48 |
---|---|
High | 32.55 |
Low | 30.98 |
Bid | 31.00 |
Offer | 31.14 |
Previous close | 32.38 |
Average volume | 428.45k |
---|---|
Shares outstanding | 26.93m |
Free float | 24.58m |
P/E (TTM) | -- |
Market cap | 872.05m USD |
EPS (TTM) | -4.02 USD |
Data delayed at least 15 minutes, as of May 23 2024 18:54 BST.
More ▼